Tevogen Bio Holdings Inc. (TVGN) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 59.05K | 85.79K | 0 | 0 | 0 | 103.55K | 101.74K | 99.99K | 98.3K | 100.87K | 93.58K | 92.7K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -59.05K | -85.79K | 0 | 0 | 0 | -103.55K | -101.74K | -99.99K | -98.3K | -100.87K | -93.58K | -92.7K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 17.15% | 100% | 100% | 100% | -2.65% | -8.72% | -7.86% | - | - | - | - |
| Operating Expenses | 5.34M | 4.52M | 5.73M | 5.44M | 10.36M | 9.26M | 5.98M | 8.5M | 29.42M | 1.91M | 2.23M | 2.09M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.27M | 2.5M | 2.62M | 2.74M | 7.16M | 6.42M | 2.72M | 4.37M | 8.71M | 1M | 1.11M | 1.06M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 3.13M | 2.11M | 3.11M | 2.7M | 3.2M | 2.84M | 3.26M | 4.12M | 20.81M | 908.05K | 1.12M | 1.03M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -59.05K | -85.79K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.4M | -4.61M | -5.73M | -5.44M | -10.36M | -9.36M | -6.09M | -8.6M | -29.52M | -2.01M | -2.33M | -2.18M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 47.85% | 50.76% | 5.85% | 36.68% | 64.91% | -366% | -161.74% | -293.64% | -1169.93% | -844.26% | -1069.33% | -744.78% |
| EBITDA | -5.34M | -4.52M | -5.44M | -5.42M | -10.25M | -9.26M | -5.98M | -8.5M | -29.42M | -1.91M | -2.23M | -2.09M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 47.89% | 51.14% | 9.12% | 36.25% | 65.15% | -385.21% | -168.16% | -306.31% | -1217.4% | -11307.05% | -1034.23% | -1110.53% |
| D&A (Non-Cash Add-back) | 59.05K | 85.79K | 291.42K | 26.59K | 105.4K | 103.55K | 101.74K | 99.99K | 98.3K | 100.87K | 93.58K | 92.7K |
| EBIT | -5.52M | -4.61M | -5.66M | -5.5M | -10.34M | -9.43M | -5.87M | -9.66M | 11.42M | -3.31M | -3.61M | -21.88M |
| Net Interest Income | 71.17K | -70.67K | -62.34K | -38.03K | -24.57K | -15.8K | -12.46K | 6 | -155.79K | 632.8K | -299.94K | -299.89K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 632.8K | 0 | 0 |
| Interest Expense | -71.17K | 70.67K | 62.34K | 38.03K | 24.57K | 15.8K | 12.46K | 0 | 155.79K | 0 | 299.94K | 299.89K |
| Other Income/Expense | -45.34K | -67.38K | 2.62K | -59.44K | -10.71K | -81.34K | 201.3K | -1.06M | 40.78M | -1.62M | -1.58M | -20M |
| Pretax Income | -5.45M | -4.68M | -5.73M | -5.5M | -10.37M | -9.44M | -5.88M | -9.66M | 11.26M | -3.63M | -3.9M | -22.18M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -5.45M | -4.68M | -5.73M | -5.5M | -10.37M | -9.25M | -5.91M | -6.05M | 11.26M | -3.63M | -3.9M | -22.18M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 47.47% | 49.43% | 3.09% | 9.03% | -192.03% | -154.66% | -51.33% | 72.73% | 136.63% | -238.93% | -342.11% | -10817.18% |
| Net Income (Continuing) | -5.45M | -4.68M | -5.73M | -5.5M | -10.37M | -9.44M | -5.88M | -9.66M | 11.26M | -3.63M | -3.9M | -22.18M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.61 | -1.20 | -1.50 | -1.53 | -3.26 | -2.60 | -1.74 | -1.97 | -13.00 | -0.26 | -1.24 | -8.00 |
| EPS Growth % | 50.54% | 53.85% | 13.54% | 22.34% | 74.96% | -919.61% | -40.49% | 75.38% | 0% | -109.36% | -173.51% | -3820.93% |
| EPS (Basic) | -1.61 | -1.20 | -1.50 | -1.53 | -3.26 | -2.60 | -1.74 | -1.97 | 4.00 | -0.26 | -1.24 | -8.00 |
| Diluted Shares Outstanding | 3.49M | 3.32M | 3.92M | 3.69M | 3.23M | 3.56M | 3.4M | 3.08M | 2.85M | 3.24M | 3.16M | 2.78M |
| Basic Shares Outstanding | 3.49M | 3.32M | 3.92M | 3.69M | 3.23M | 3.56M | 3.4M | 3.08M | 2.75M | 3.24M | 3.16M | 2.78M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |